SARS: Nigerian youth, celebrities protest against controversial ...

CNN - 10 Oct 2020
Nigeria's leading celebrities and activists have organized mass protests across major cities in the country Friday demanding an end to police brutality in the ...

Statement on the antigen composition of COVID-19 vaccines

World Health Organization (WHO) - 26 Apr 2024
Statement on the antigen composition of COVID-19 vaccines ...

Nasal vaccination of triple-RBD scaffold protein with flagellin elicits long-term protection against SARS-CoV-2 variants ...

Nature.com - 27 Apr 2024
Nasal vaccination of triple-RBD scaffold protein with flagellin elicits long-term protection against SARS-CoV-2 variants ... ...

The Impact of SARS-CoV-2 on Patients With Lower Urinary Tract Symptoms (LUTS)

Cureus - 27 Apr 2024
The Impact of SARS-CoV-2 on Patients With Lower Urinary Tract Symptoms (LUTS) ...

New tARC-seq method enhances precision in tracking SARS-CoV-2 mutations

News-Medical.Net - 24 Apr 2024
New tARC-seq method enhances precision in tracking SARS-CoV-2 mutations ...

US respiratory virus levels continue to decline as officials track shift in SARS-CoV-2 proportions

University of Minnesota Twin Cities - 26 Apr 2024
US respiratory virus levels continue to decline as officials track shift in SARS-CoV-2 proportions ...

SARS-CoV-2 fragments may cause problems after infection

National Institutes of Health (NIH) (.gov) - 27 Feb 2024
SARS-CoV-2 fragments may cause problems after infection ...

SARS-CoV-2 vaccine efficacy in Latin American countries

Fred Hutchinson Cancer Center - 17 Apr 2024
SARS-CoV-2 vaccine efficacy in Latin American countries ...

Communique on SARS-CoV-2 BA.2.86 sub-variant – Africa CDC

africacdc.org - 06 Sep 2023
Communique on SARS-CoV-2 BA.2.86 sub-variant – Africa CDC ...

Sars's AI-enhanced audit capabilities wreaking havoc on taxpayers

Moneyweb - 25 Apr 2024
Sars's AI-enhanced audit capabilities wreaking havoc on taxpayers ...

Laboratory biosafety guidance related to SARS-CoV-2 (COVID-19): Interim guidance, 11 March 2024

World Health Organization (WHO) - 11 Mar 2024
Laboratory biosafety guidance related to SARS-CoV-2 (COVID-19): Interim guidance, 11 March 2024 ...

Quality control in SARS-CoV-2 RBD-Fc vaccine production using LC–MS to confirm strain selection and detect ...

Nature.com - 26 Apr 2024
Quality control in SARS-CoV-2 RBD-Fc vaccine production using LC–MS to confirm strain selection and detect ... ...

Study suggests lingering coronavirus in tissues may contribute to long COVID symptoms

News-Medical.Net - 26 Apr 2024
Study suggests lingering coronavirus in tissues may contribute to long COVID symptoms ...

How lung distress from SARS-CoV-2 can cause heart damage

National Institutes of Health (NIH) (.gov) - 02 Apr 2024
How lung distress from SARS-CoV-2 can cause heart damage ...

Ambient carbon dioxide concentration correlates with SARS-CoV-2 aerostability and infection risk

Nature.com - 25 Apr 2024
Ambient carbon dioxide concentration correlates with SARS-CoV-2 aerostability and infection risk ...

Research highlights emergence of immune-evasive SARS-CoV-2 variants in immunocompromised patients

News-Medical.Net - 18 Apr 2024
Research highlights emergence of immune-evasive SARS-CoV-2 variants in immunocompromised patients ...

Mucosal prime-boost immunization with live murine pneumonia virus-vectored SARS-CoV-2 vaccine is protective in ...

Nature.com - 26 Apr 2024
Mucosal prime-boost immunization with live murine pneumonia virus-vectored SARS-CoV-2 vaccine is protective in ... ...

Does diabetes increase the risk of long COVID?

News-Medical.Net - 23 Apr 2024
Does diabetes increase the risk of long COVID? ...

Targeted accurate RNA consensus sequencing (tARC-seq) reveals mechanisms of replication error affecting SARS ...

Nature.com - 22 Apr 2024
Targeted accurate RNA consensus sequencing (tARC-seq) reveals mechanisms of replication error affecting SARS ... ...

Age-specific nasal epithelial responses to SARS-CoV-2 infection

Nature.com - 15 Apr 2024
Age-specific nasal epithelial responses to SARS-CoV-2 infection ...

SARS